Polina A. Egorova

Polina A. Egorova

Auto-generated profile, based on publicly available information

Polina A. Egorova

Laboratory of Molecular Neurodegeneration, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KMKsenia S. Marinina
Ksenia S. Marinina
IBIlya Bezprozvanny
Ilya Bezprozvanny
PEPolina A. Egorova
Polina A. Egorova
Spinocerebellar ataxia type 2 (SCA2) is a polyglutamine disorder caused by a pathological expansion of CAG repeats in ATXN2 gene. SCA2 is accompanied by cerebellar degeneration and progressive motor decline. Cerebellar Purkinje cells (PCs) seem to be primarily affected in this disorder. The majority of the ataxia research is focused on the motor decline observed in ataxic patients and animal models of the disease. However, recent evidence from patients and ataxic mice suggests that SCA2 can also share the symptoms of the cerebellar cognitive affective syndrome. We previously reported that SCA2-58Q PC-specific transgenic mice exhibit anxiolytic behavior, decline in spatial memory, and a depressive-like state. Here we studied the effect of the activation of the small conductance calcium-activated potassium channels (SK channels) by chlorzoxazone (CHZ) combined with the folic acid (FA) on the PC firing and also motor, cognitive and affective symptoms in SCA2-58Q mice. We realized that CHZ-FA combination improved motor and cognitive decline as well as ameliorated mood alterations in SCA2-58Q mice without affecting the firing rate of their cerebellar PCs. Our results support the idea of the combination therapy for both ataxia and non-motor symptoms in ataxic mice without affecting the firing frequency of PCs.

3 June 2020 in Vestnik of Minin University
Verified
Journal Article
Open access
PDF file
PKPavel Kislyakov
Pavel Kislyakov
IMI.-L. S. Meyerson
I.-L. S. Meyerson
PEP. A. Egorova
P. A. Egorova
Introduction. The article analyzes the problem of psychological stability of the individual to socio-cultural threats and negative information impact. As social problems become more acute, the topic of personal security and resistance to emerging threats and risks takes an increasing place in the scientific literature. Today we can observe various violations of the processes of socio-cultural identification, which reduce the adaptive potential of the individual. The reverse side of accessibility in the global information environment is an increase in the degree of danger, the emergence of new risk factors and threats of information and psychological impact. Of particular concern are the facts of Russian youth joining terrorist groups, as well as the facts of youth involvement in destructive protest movements and actions.Materials and methods. The following methods were used for the preparation of this article; theoretical analysis of Russian and international literature, study of scientific articles and publications on the topic, overview of results from Russian and international studies, content analysis.Results. Approaches to determining the content of the category of psychological stability of a person and its various aspects are considered: emotional stability, moral stability, moral stability, stability of behavior forms, resistance to addictive factors, and socio-cultural stability. Identify invariant indicators that determine the psychological stability of the individual in various contexts of countering socio-cultural threats and negative information impact: socio-cultural identity based on views, beliefs, attitudes consistent with moral norms and spiritual values; motivation of the individual to self-actualization, success, openness and commitment to society; subjective well-being and resilience; critical thinking and the ability to predict risks and threats; possession of constructive coping strategies; adaptive personal potential expressed in mastering self-regulation methods that ensure successful adaptation to a changing socio-cultural environment.Discussion and Conclusions. The conducted theoretical research allowed us to conclude that the psychological stability of a person is a complex and multidimensional phenomenon, which is revealed in the moral, socio-psychological and system-activity perspective. It is concluded that the task of forming psychological stability and personal adaptive potential should be updated in the educational system, including the formation of knowledge about oneself as a person, about their psychological capabilities and mechanisms of self-regulation, and the explanation of moral norms and values.

21 January 2023 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
KMKsenia S. Marinina
Ksenia S. Marinina
IBIlya Bezprozvanny
Ilya Bezprozvanny
PEPolina A. Egorova
Polina A. Egorova

20 October 2023 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
KMKsenia S Marinina
Ksenia S Marinina
IBIlya Bezprozvanny
Ilya Bezprozvanny
PEPolina A Egorova
Polina A Egorova
Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant hereditary disorder, caused by an expansion of polyglutamine in the ataxin-3 protein. SCA3 symptoms include progressive motor decline caused by an atrophy of the cerebellum and brainstem. However, it was recently reported that SCA3 patients also suffer from the cerebellar cognitive affective syndrome. The majority of SCA3 patients exhibit cognitive decline and approximately half of them suffer from depression and anxiety. The necessity to find a combined therapy for both motor and cognitive deficits in a SCA3 mouse model is required for the development of SCA3 treatment. Here, we demonstrated that the SCA3-84Q transgenic mice exhibited anxiety over the novel brightly illuminated environment in the open field, novelty suppressed feeding, and light-dark place preference tests. Moreover, SCA3-84Q mice also suffered from a decline in recognition memory during the novel object recognition test. SCA3-84Q mice also demonstrated floating behavior during the Morris water maze that can be interpreted as a sign of low mood and aversion to activity, i.e. depressive-like state. SCA3-84Q mice also spent more time immobile during the forced swimming and tail suspension tests which is also evidence for depressive-like behavior. Therefore, the SCA3-84Q mouse model may be used as a model system to test the possible treatments for both ataxia and non-motor symptoms including depression, anxiety, and memory loss.

10 May 2024 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
KMKsenia S Marinina
Ksenia S Marinina
IBIlya B Bezprozvanny
Ilya B Bezprozvanny
PEPolina A Egorova
Polina A Egorova
Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease, is reported to be the most common type of autosomal dominant cerebellar ataxia (ADCA). SCA3 patients suffer from a progressive decline in motor coordination and other disease-associated symptoms. Moreover, recent studies have reported that SCA3 patients also exhibit symptoms of cerebellar cognitive affective syndrome (CCAS). We previously observed signs of CCAS in mouse model of SCA3. Particularly, SCA3-84Q mice suffer from anxiety, recognition memory decline, and also exhibit signs of low mood and aversion to activity. Here we studied the effect of long-term injections of SK channels activator chlorzoxazone (CHZ) together and separately with the folic acid (FA) on the cerebellar Purkinje cell (PC) firing and histology, and also on the motor and cognitive functions as well as mood alterations in SCA3-84Q hemizygous transgenic mice. We realized that both CHZ and CHZ-FA combination had similar positive effect on pure cerebellum impairments including PC firing precision, PC histology, and motor performance in SCA3-84Q mice. However, only the CHZ-FA combination, but not CHZ, had significantly ameliorated the signs of anxiety and depression, and also noticeably improved recognition memory in SCA3-84Q mice. Our results suggest that the combination therapy for both ataxia and non-motor symptoms is required for the complex treatment of ADCA.

12 November 2024 in Journal of Huntington's Disease
Verified
Journal Article
Closed access
KMKsenia S Marinina
Ksenia S Marinina
IBIlya Bezprozvanny
Ilya Bezprozvanny
PEPolina A Egorova
Polina A Egorova
Background: Huntington’s disease (HD) is an autosomal dominant hereditary disorder, caused by an expansion of polyglutamine in the huntingtin protein. HD is characterized by a progressive decline in motor functions. This decline includes involuntary movements (chorea) and the worsening of controlled motions caused mainly by neuronal dysfunction in the striatum. In addition to the deterioration of motor symptoms, HD patients also suffer from cognitive changes, mood swings, apathy, depression, outbursts of anger, psychosis, and social withdrawal. Objective: A comprehensive examination of cognitive, affective, and social changes in the HD mouse model is required for the development of combined therapy for both motor and non-motor deficits in HD. Methods: The behavioral tests for anxiety, memory, and social traits were used in this study. Results: YAC128 HD transgenic mice exhibited anxiolytic behavior in the novel brightly illuminated environment of the open field and light-dark place preference tests. Moreover, YAC128 HD mice also suffered from a decline in their recognition memory during the novel object recognition test. YAC128 HD mice demonstrated reduced exploration interest during the open field with a non-social target as well as during the first day of the three-chamber social test. Social interaction was also impaired in YAC128 HD mice as it was shown in the social interaction with resident intruder test. Conclusions: YAC128 HD mouse model may be used as a model system to test the possible treatments for both motor and non-motor symptoms including memory loss, agitation and social withdrawal.